T, G., T, M., F, G., J, N., ER, J., A, S., . . . M, M. (2021). Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes. Frontiers in pharmacology, 12, 634477. https://doi.org/10.3389/fphar.2021.634477
Chicago Style (17th ed.) CitationT, Gasperetti, et al. "Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes." Frontiers in Pharmacology 12 (2021): 634477. https://doi.org/10.3389/fphar.2021.634477.
MLA (9th ed.) CitationT, Gasperetti, et al. "Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes." Frontiers in Pharmacology, vol. 12, 2021, p. 634477, https://doi.org/10.3389/fphar.2021.634477.
Warning: These citations may not always be 100% accurate.